Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves
NCT02696226Terminated
- Sponsor
- Cleveland Clinic
- Start
- Feb 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of warfarin in Leaflet thrombosis (4 arms), sponsored by Cleveland Clinic. Primary endpoint: Leaflet Motion. Started Feb 2016; status: terminated.
02
Drugs
warfarin
03
Conditions
Leaflet thrombosis
Beyond the preview
Go deeper on NCT02696226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02696226.